Chugai Pharmaceutical Co., Ltd. ( CHGCY) - Key Metrics
CHGCY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $210.43 | $78.03 | $79.02 | $68.47 |
| 2025Q3 | $202.45 | $67.58 | $43.79 | $37.73 |
| 2025Q2 | $176.22 | $59.04 | $72.92 | $56.62 |
| 2025Q1 | $175.30 | $59.09 | $40.92 | $27.49 |
CHGCY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 0.10% | 26.41 |
| 2025Q3 | 184.96% | 23.85 |
| 2025Q2 | 0.45% | 31.87 |
| 2025Q1 | 96.07% | 28.77 |
CHGCY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.78% | ? |
| 2025Q4 | 0.86% | 0.00% |
| 2025Q3 | 0.60% | 1.94% |
| 2025Q2 | 0.75% | 0.00% |
| 2025Q1 | 0.40% | 0.83% |
CHGCY
Price: $22.84
52 week price:
Dividend Yield: 3.75%
Payout Ratio Range:
Earnings Per Share: 0.82 USD
P/E Ratio: 28.59
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 76.2 billion